Biotronik Wants $100M Suit Over J&J Stent Recall Reopened
German drugmaker Biotronik AG asked a New York state appeals court Tuesday to allow it to seek $100 million in lost profits after a Johnson & Johnson unit's stent recall, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article